Clinical Trial Update: Strategic Use of New Generation Antidepressants for Depression [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the strategic use of new-generation antidepressants for major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Kyoto University | Conditions: Unipolar Major Depressive Episode | Phase 4 | Status: COMPLETED